{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:17:10Z","timestamp":1790979430282,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["The medical writing was funded by Boehringer Ingelheim"],"award-info":[{"award-number":["The medical writing was funded by Boehringer Ingelheim"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40257-021-00663-y","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:02:48Z","timestamp":1642752168000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey"],"prefix":"10.1007","volume":"23","author":[{"given":"Dale V.","family":"Reisner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida Dunger","family":"Johnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Kotowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Brunette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell","family":"Valdecantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Koks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/ijd.12070","volume":"53","author":"SE Choon","year":"2014","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53:676\u201384.","journal-title":"Int J Dermatol"},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jaad.2014.04.063","volume":"71","author":"J Chung","year":"2014","unstructured":"Chung J, Callis Duffin K, Takeshita J, Shin DB, Krueger GG, Robertson AD, et al. Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2014;71:623\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2340\/00015555-1193","volume":"92","author":"E Hrehorow","year":"2012","unstructured":"Hrehorow E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67\u201372.","journal-title":"Acta Derm Venereol"},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365:620\u20138.","journal-title":"N Engl J Med"},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"adv00034","DOI":"10.2340\/00015555-3388","volume":"100","author":"H Bachelez","year":"2020","unstructured":"Bachelez H. Pustular psoriasis: the dawn of a new era. Acta Derm Venereol. 2020;100:adv00034.","journal-title":"Acta Derm Venereol"},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/bjd.18203","volume":"181","author":"E Sbidian","year":"2019","unstructured":"Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, et al. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol. 2019;181:1304\u20136.","journal-title":"Br J Dermatol"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00325481.2020.1831315","volume":"133","author":"JJ Crowley","year":"2021","unstructured":"Crowley JJ, Pariser DM, Yamauchi PS. A brief guide to pustular psoriasis for primary care providers. Postgrad Med. 2021;133:330\u201344.","journal-title":"Postgrad Med"},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","volume":"32","author":"R Goiriz","year":"2007","unstructured":"Goiriz R, Daud\u00e9n E, P\u00e9rez-Gala S, Guhl G, Garc\u00eda-D\u00edez A. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol. 2007;32:176\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2340\/00015555-0777","volume":"90","author":"AM Brunasso","year":"2010","unstructured":"Brunasso AM, Laimer M, Massone C. Paradoxical reactions to targeted biological treatments: a way to treat and trigger? Acta Derm Venereol. 2010;90:183\u20135.","journal-title":"Acta Derm Venereol"},{"key":"663_CR11","first-page":"131","volume":"6","author":"KE Benjegerdes","year":"2016","unstructured":"Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131\u201344.","journal-title":"Psoriasis (Auckl)"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/1346-8138.15657","volume":"48","author":"K Hayama","year":"2021","unstructured":"Hayama K, Fujita H, Iwatsuki K, Terui T. Improved quality of life of patients with generalized pustular psoriasis in Japan: a cross-sectional survey. J Dermatol. 2021;48:203\u20136.","journal-title":"J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00663-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00663-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00663-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:47:00Z","timestamp":1643575620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00663-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00663-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"24 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been published as part of a journal supplement wholly funded by Boehringer Ingelheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"Medical writing support was funded by Boehringer Ingelheim.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Kilian Eyerich has received consulting fees from AbbVie, Almirall, Bristol Myers Squibb, LEO Pharma, Janssen, Lilly, Novartis, UCB, Pfizer, and Boehringer Ingelheim; grants and\/or contracts from AbbVie, LEO Pharma, UCB, and Lilly; and speaking fees from AbbVie, LEO Pharma, Janssen, and Lilly. Kilian Eyerich also declares stock or stock options with Dermagnostix and Dermagnostix R&D. Nirali Kotowsky was employed by Boehringer Ingelheim at the time the study was conducted. Wendell Valdecantos and Steven Brunette are full-time employees of Boehringer Ingelheim.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This survey received a formal Exemption from a central Institutional Review Board (IRB) on June 8, 2020, and was provided by the IRB of Advarra<sup>TM<\/sup> (formerly IntegReview).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The participants of this research study voluntarily agreed to participate.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The participants of this research study gave their consent for the publication.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The sponsor of the supplement and all authors identified and discussed the concept for each chapter and the supplement as a whole; further development of this original research article was at the direction of the authors, who provided guidance to OPEN Health Communications on the content of the article, critically revised the work, and approved the content for publication.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}